Primex Pharmaceuticals Ltd.

Primex Pharmaceuticals Ltd. is an international specialty pharmaceutical company based in Helsinki, Finland. Primex is an innovative and fast-growing company spearheading a new pharmaceutical business model. Primex' products are available in a total of 30 countries world-wide, while its distribution reaches a population of half a billion (500 million) people. The goal is to be a globally recognized supplier of high quality products in our chosen specialties such as anesthesia, oncology, gastroenterology and intensive care.

Primex supplies high-quality medicines to healthcare institutions and professionals around the world, from the EU to Asia, and from Latin America to the Middle East. There are unique medicines for hospital use and specialty practices. The main products are Recofol® for anesthesia in hospitals and clinics, and Dobuject® for acute heart failure in intensive care units. Primex' pharmaceutical products are manufactured in the EU under the strictest quality controls.

Primex is committed to building a profitable long-term business with its affiliates and partners. The Primex Alliance Network, connecting leading regional businesses and deep market knowledge, creates irreplaceable value and forms a strong base for the future of the whole network in all parts of the world. Primex is actively looking for new products and partners globally. Please do not hesitate to contact us!

Contact information:
Corporate Management
Mariankatu 21 C, FI-00170 Helsinki, Finland
Phone: +358 503 002 388

Partners and Alliances, Intl Inquiries
Phone: +358 400 602 089 or +358 505 371 339